GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Danaher Corp (NYSE:DHR) » Definitions » EPS without NRI

Danaher (Danaher) EPS without NRI

: $7.62 (TTM As of Dec. 2023)
View and export this data going back to 1986. Start your Free Trial

Danaher's earnings per share without non-recurring items for the three months ended in Dec. 2023 was $2.09. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was $7.62.

During the past 12 months, Danaher's average earnings per share (NRI) Growth Rate was -13.80% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 20.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 23.70% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Danaher's EPS without NRI or its related term are showing as below:

DHR' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -39.8   Med: 14.85   Max: 172.3
Current: 20

During the past 13 years, Danaher's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 172.30% per year. The lowest was -39.80% per year. And the median was 14.85% per year.

DHR's 3-Year EPS without NRI Growth Rate is ranked better than
69.94% of 173 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.2 vs DHR: 20.00

Danaher's EPS (Diluted) for the three months ended in Dec. 2023 was $1.45. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $6.39.

Danaher's EPS (Basic) for the three months ended in Dec. 2023 was $1.46. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $6.45.


Danaher EPS without NRI Historical Data

The historical data trend for Danaher's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danaher Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.27 4.39 6.94 8.80 7.58

Danaher Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS without NRI Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.87 1.92 2.05 1.56 2.09

Competitive Comparison

For the Diagnostics & Research subindustry, Danaher's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danaher PE Ratio without NRI Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Danaher's PE Ratio without NRI falls into.



Danaher EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Danaher  (NYSE:DHR) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Danaher EPS without NRI Related Terms

Thank you for viewing the detailed overview of Danaher's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Danaher (Danaher) Business Description

Address
2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
Executives
Jose-carlos Gutierrez-ramos officer: SVP, Chief Scientific Officer C/O MOMENTA PHARMACEUTICALS, INC., 675 WEST KENDALL STREET, CAMBRIDGE MA 02142
Linda Filler director 2200 PENNSYLVANIA AVE NW, SUITE 800W, WASHINGTON DC 20037
Daniel Raskas officer: VP-Corporate Development 2099 PENNSYLVANIA AVENUE, NORTHWEST, WASHINGTON DC 20006
Teri List director 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Joakim Weidemanis officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Walter G Lohr director DANAHER CORP, 2099 PENNSYLVANIA AVE NW 12TH FL, WASHINGTON DC 20006
Georgeann Couchara officer: SVP, Human Resources 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Raymond C Stevens director 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Matthew Mcgrew officer: EVP & Chief Financial Officer 2200 PENNSYLVANIA AVENUE, NW, SUITE 800 W, WASHINGTON DC 20010
Jennifer Honeycutt officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Alan G Spoon director 1150 15TH ST NW, WASHINGTON DC 20071
Rainer Blair officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Feroz Dewan director C/O ARENA HOLDINGS MANAGEMENT LLC, 119 FIFTH AVENUE - 8TH FLOOR, NEW YORK NY 10003
Mitchell P Rales director, officer: Chairman of Exec. Committee 11790 GLEN ROAD, POTOMAC MD 20854
Brian W Ellis officer: Senior Vice President - GC 2200 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20037

Danaher (Danaher) Headlines

From GuruFocus

Q2 2022 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Danaher Corp Investor and Analyst Meeting Transcript

By GuruFocus Research 01-22-2024

Danaher Corp Annual Shareholders Meeting Transcript

By GuruFocus Research 01-22-2024

Q3 2021 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2023 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2022 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2020 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024